Lilly Targets Pharma Cos. In Gemzar ITC Suit
Eli Lilly and Co. has filed a complaint with the U.S. International Trade Commission against Hospira Inc., Intas Pharmaceuticals Ltd. and others over attempts to introduce generic versions of the cancer...To view the full article, register now.
Already a subscriber? Click here to view full article